Seems to me that we are slowly establishing a niche for ourselves and filling it. Meanwhile our R&D progresses and our sequencers get faster and with cheaper output. As i mentioned before....All it takes is for the long sequence reads to prove critical in diagnosing a common disease, and we are in.